Canadian researchers are the first to study how different patterns in the way older adults walk could more accurately diagnose different types of dementia and identify Alzheimer’s disease.
A new study by a Canadian
research team, led by London researchers from Lawson Health Research Institute
and Western University, evaluated the walking patterns and brain function of
500 participants currently enrolled in clinical trials. Their findings are published
today in Alzheimer’s
& Dementia: The Journal of the Alzheimer’s Association.
“We have longstanding
evidence showing that cognitive problems, such as poor memory and executive
dysfunction, can be predictors of dementia. Now, we’re seeing that motor performance,
specifically the way you walk, can help diagnose different types of
neurodegenerative conditions,” says Dr. Manuel Montero-Odasso, Scientist at
Lawson and Professor at Western’s Schulich School of Medicine & Dentistry.
Dr. Montero-Odasso is world
renowned for his research on the relationship between mobility and cognitive
decline in aging. Leading the Mobility, Exercise and Cognition (MEC) team in
London, he is pioneering novel diagnostic approaches and treatments to prevent
and combat early dementia.
This study compared gait
impairments across the cognitive spectrum, including people with Subjective
Cognitive Impairment, Parkinson’s Disease, Mild Cognitive Impairment,
Alzheimer’s disease, Lewy body dementia and Frontotemporal dementia, as well as
cognitively healthy controls.
Four independent gait
patterns were identified: rhythm, pace, variability and postural control. Only
high gait variability was associated with lower cognitive performance and it
identified Alzheimer’s disease with 70 percent accuracy. Gait variability means
the stride-to-stride fluctuations in distance and timing that happen when we
walk.
“This is the first strong
evidence showing that gait variability is an important marker for processes
happening in areas of the brain that are linked to both cognitive impairment
and motor control,” notes Dr. Frederico Perruccini-Faria, Research Assistant at
Lawson and Postdoctoral Associate at Western’s Schulich School of Medicine
& Dentistry, who is first author on the paper. “We’ve shown that high gait
variability as a marker of this cognitive-cortical dysfunction can reliably
identify Alzheimer’s disease compared to other neurodegenerative disorders.”
When cognitive-cortical
dysfunction is happening, the person’s ability to perform multiple tasks at the
same time is impacted, such as talking while walking or chopping vegetables
while chatting with family.
Having gait variability as a
motor marker for cognitive decline and different types of conditions could
allow for gait assessment to be used as a clinical test, for example having
patients use wearable technology. “We see gait variability being similar to an
arrhythmia. Health care providers could measure it with patients in the clinic,
similar to how we assess heart rhythm with electrocardiograms,” adds Dr.
Montero-Odasso.
Source: https://www.lawsonresearch.ca/
Journal article: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12298
No comments:
Post a Comment